Clinical Features and Natural History of von Hippel-Lindau Disease

Clicks: 1
ID: 300231
1990
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #44 of 111 articles by views in qjm : monthly journal of the association of physicians

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The Clinical features, age at onset and survival of 152 patients with von Hippel-Lindau disease were studied. Mean age at onset was 26.3 years and 97 per cent of patients had presented by aged 60 years. Retinal angioma was the first manifestation in 65 patients (43 per cent), followed by cerebellar haemangioblastoma (n = 60, 39 per cent) and renal cell carcinoma (n = 15, 10 per cent). Overall, 89 patients (59 per cent) developed a cerebellar haemagioblastoma, 89 (59 percent) a retinal angioma, 43 (28 percent)renal cell carcinoma, 20 (13 per cent) spinal haemangioblastoma and 11 (7 per cent) a phaeochromocytoma. Renal, pancreatic and epididymal cysts were frequent findings but their exact incidence was not accurately assessed. Mean age at diagnosis of renal cell carcinoma (44.0±10.9 years) was significantly older than that for cerebellar haemangioblastoma (29.0±10.0 years) and retinal angioma (25.4±12.7 years). The probability of a patient with von Hippel-Lindan disease developing a cerebellar haemangioblastoma, retinal angioma or renal cell carcinoma by age 60 years was 0.84, 0.7 and 0.69, respectively. A comprehensive screening protocol for affected patients and at-risk relatives is presented, based on detailed analysis of age at onset data for each of the major complications. Median actuarial survival was 49 years, with renal cell carcinoma the leading cause of death.
Reference Key
openalex_W2090789862 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Eamonn R. Maher, John R.W. Yates, R W J Harries, Caroline Benjamin, R Harris, Anthony T. Moore, M.A. Ferguson‐Smith
Journal qjm : monthly journal of the association of physicians
Year 1990
DOI
10.1093/qjmed/77.2.1151
URL
https://doi.org/10.1093/qjmed/77.2.1151
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.